For all the MAPK pathways tested, we observed that the expression of DEPDC1B proteins in oral cancer cells induced p38 MAPK and ERK activity; however, it suppressed JNK activation (Figure 4A). This evidence concerns the gene DEPDC1B and lip and oral cavity carcinoma.